Find uplifting stories about heroes, innovations, and solutions
52 results for "psilocybin"
A woman with advanced Alzheimer's disease showed remarkable improvements in speech and memory after taking psilocybin mushrooms, according to a new medical case report. The unexpected turnaround is sparking hope for new treatment approaches to the devastating condition. #
A psychedelic treatment could soon offer new hope for people with severe depression who haven't found relief from traditional medicines. Two major clinical trials show the psilocybin therapy helped patients improve more than standard care.
Scientists discovered that one dose of psilocybin, the compound in magic mushrooms, can create measurable changes in brain structure that last at least a month. The findings could explain why psychedelics show promise in treating depression, anxiety, and addiction.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
An 80-year-old woman who hadn't spoken in five years began talking for hours just 19 hours after taking psilocybin mushrooms. The breakthrough case study suggests that cognitive abilities lost to Alzheimer's might not be gone forever, just hidden.
A breakthrough study shows a single dose of psilocybin, combined with therapy, dramatically reduced chronic suicidal thoughts in people who had run out of options. After 12 weeks, 70% of participants reported minimal or no suicidal ideation.
University of South Florida researchers are running clinical trials using psilocybin to help people with serious mental health conditions. The studies could open new treatment paths for patients who haven't found relief through traditional therapies.
Virginia lawmakers just passed groundbreaking legislation to help veterans struggling with depression and PTSD. Once the FDA approves psilocybin-based medicine, veterans will have immediate legal access to this promising treatment.
A Colorado woman battling stage III uterine cancer joined a groundbreaking study combining psilocybin with therapy to treat anxiety and depression. The results transformed how she lives with her diagnosis.
New Mexico just set aside $630,000 to ensure low-income and rural residents can access groundbreaking psilocybin therapy for treatment-resistant depression and PTSD. The state is creating the nation's first medically integrated psilocybin program, launching by end of 2026.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. Even the researchers were stunned by how powerful the results turned out to be.
A woman who hadn't spoken clearly in years suddenly engaged in hours of conversation after taking psilocybin mushrooms in a Brazilian study. The case offers a glimpse of hope for Alzheimer's treatment, though scientists urge caution about drawing broad conclusions from a single patient.
An 80-year-old woman with advanced Alzheimer's disease began speaking, walking, and recognizing family members again after receiving psilocybin mushrooms. While scientists urge caution about this single case, it's opening new questions about hidden potential in damaged brains.
An 80-year-old woman who hadn't spoken in five years suddenly began talking for hours after receiving psilocybin treatment. The breakthrough challenges everything we thought we knew about Alzheimer's recovery.
A breakthrough treatment using psilocybin-assisted therapy is nearing FDA approval, offering hope to millions with treatment-resistant depression and PTSD. After decades without new psychiatric treatments, this could revolutionize how we heal mental illness.
A second major clinical trial shows psilocybin therapy significantly reduces treatment-resistant depression. The breakthrough brings new hope to millions who haven't found relief from traditional antidepressants.
Five years after taking psilocybin mushrooms with therapy, two-thirds of depression patients remain in complete remission. Even those still struggling report their depression feels far more manageable than before treatment.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. It's the first potential new smoking cessation medication in 20 years.
New research shows that a single dose of psilocybin combined with therapy helped smokers quit at six times the rate of traditional nicotine patches. After decades without new smoking cessation tools, this breakthrough could offer hope to millions trying to kick the habit.
A groundbreaking clinical trial found that a single dose of psilocybin helped people struggling with cocaine addiction stay sober longer than a placebo. This could be the first real treatment option for the rising tide of stimulant overdoses claiming more lives each year.
Showing 20 of 52